ENTA — Enanta Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $339.02m
- $275.90m
- $65.32m
Enanta Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Enanta Pharmaceuticals Q3 revenue rises slightly
Enanta Pharmaceuticals Inc expected to post a loss of $1.28 a share - Earnings Preview
Enanta Pharmaceuticals Inc expected to post a loss of $1.28 a share - Earnings Preview
AbbVie, Enanta Pharma rise after US FDA approves pediatric use of hepatitis C drug
Enanta Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Enanta Pharmaceuticals Q2 Revenue USD 14.926 Million
Enanta Pharmaceuticals Inc expected to post a loss of $1.14 a share - Earnings Preview
Enanta Pharmaceuticals Inc expected to post a loss of $1.14 a share - Earnings Preview
Brief: Enanta Pharmaceuticals Announces Respiratory Syncytial Virus Data Presentation At Escmid Global 2025
Enanta Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Enanta Pharmaceuticals Inc QTRLY Loss Per Share $1.05
Brief: Enanta Pharmaceuticals Q1 Revenue USD 16.959 Million
Enanta Pharmaceuticals Inc expected to post a loss of $1.35 a share - Earnings Preview
Enanta Pharmaceuticals Inc expected to post a loss of $1.35 a share - Earnings Preview
U.S. RESEARCH ROUNDUP-BTCS, Gevo, ServiceNow
Brief: Enanta Pharmaceuticals Announces Positive Phase 2 Results Evaluating Zelicapavir
U.S. RESEARCH ROUNDUP-Allstate, Mongodb, Primerica
Enanta Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary